Booster shot study aims to keep teens safe from whooping cough
NCT ID NCT02118961
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a booster dose of the DTaP vaccine (BK1301) in 446 adolescents aged 11-12 who had already received the standard childhood series. The goal was to confirm the vaccine boosts immunity against diphtheria, tetanus, and pertussis (whooping cough) safely. Results showed strong immune responses, supporting its use as a booster.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIPHTHERIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inverstigational site
Kumagaya-shi, Saitama, Japan
-
Inverstigational site
Shinjuku-ku, Tokyo, Japan
-
Investigational site
Fukuoka, Fukuoka, Japan
-
Investigational site
Itoshima-shi, Fukuoka, Japan
-
Investigational site
Kasuga-shi, Fukuoka, Japan
-
Investigational site
Hiroshima, Hiroshima, Japan
-
Investigational site
Shizuoka, Shizuoka, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new vaccine shield older kids and adults from three deadly infections?
- Can a Five-Part vaccine bolster protection against three serious infections?
- Can a single shot keep tetanus at bay?
- Will a single DTP vaccine dose protect for a decade? study tracks antibodies
- Can a new tetanus shot offer stronger protection?
- Are adults in beijing still protected against tetanus? a study investigates